The FDA has approved five novel drugs so far this year. Now, let's take a look at the biotech stocks facing FDA decisions in March 2025. The views and opinions expressed herein are the views and ...
Medical Device Network on MSN1d
Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenueDexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
When you're on an airplane, the pilot or a flight attendant will typically announce over the loudspeaker to "buckle your ...
We recently compiled a list of the 12 Stocks Under $10 With High Upside Potential. In this article, we are going to take a ...
Four-star-rated analyst Daniel Grosslight at Citi reiterated his Sell rating on Hims & Hers Health (HIMS) stock yesterday, ...
QIAGEN N.V. QGEN has secured FDA clearance for its QIAstat-Dx Gastrointestinal ... Just Released: Zacks Top 10 Stocks for 2025 Hurry – you can still get in early on our 10 top tickers for ...
“The FDA’s sBLA acceptance for Gazyva recognizes the need to provide a more effective treatment option for people living with this devastating disease.” “Lupus nephritis is a debilitating ...
Stereotaxis STXS recently submitted an application seeking FDA regulatory clearance for its ... Just Released: Zacks Top 10 Stocks for 2025 Hurry – you can still get in early on our 10 top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback